About US
Contact us
-
NMPA Held the Work Conference on Promoting Foreign Trade...On November 15, 2022, in order to thoroughly implement the decisions and plans of the CPC Central Committee and the State Council, and focus on the new missions and requirements proposed in the Repor2022/11/29
-
ScPharmaceuticals prices $50M offering to fund commercialization of on-body infusorScPharmaceuticals hassecuredfunding for commercialization of its recently approved on-body infusor, pricing a $50 million public offering ahead of the planned launch of the product early next year. L2022/11/24
-
Merck's Keytruda tees up BMS stomach cancer fight with new trial winYears after Merck & Co.'s Keytruda failed to move the needle in newly diagnosed stomach cancer bearing the PD-L1 biomarker, the company has come back with a win, this time for tumorsregardless of2022/11/24
-
Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, MerckAs the fight against COVID-19 rolls on, regulators in Japan have bestowed a green light on the country's first homegrown antiviral. The win goes to local drugmaker Shionogi, which hasclinchedan em2022/11/22
-
'Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit saysThe courtroom drama surrounding Bristol Myers Squibb and its subsidiary Celgene over their efforts to restrict competition for lymphoma drug Revlimid has raged for more than a decade. And2022/11/22
-
FDA moves to boost access to overdose reversal med with preliminary over-the-counter endorsementReady access to opioid antagonists such as naloxone can make all the difference during an overdose. Now, the FDA is chipping away at one of the chief impediments keeping the potentially lifesaving dr2022/11/17
-
GSK, J&J and AZ top global drug access index, but foundation says plenty more work needs to be doneBig Pharma companies routinely say they're working on boosting drug access worldwide, but, every other year, the Access to Medicine Foundation publicly calls out shortcomings in their efforts. Whi2022/11/17
-
COVID-19 tracker: Rebounds can occur regardless of treatment with Pfizer's Paxlovid, study findsA study testing rebounds in COVID-19 patients found that symptoms can return regardless of treatment with Paxlovid. Meanwhile, GeNuero and NanoViricidesare aiming to join the COVID-19 tre2022/11/15
-
Ardelyx FDA docs portend another showdown at this week's expert hearing on kidney disease prospectThe FDA's rejection of Ardelyx’s chronic kidney disease prospect last summer drew a rebuke from the company and analysts. But as an FDA panel of outside experts gathers to re-assess the drug on Wedne2022/11/15
-
GSK's Zejula FDA oncology AdComm canceled, leaving ovarian cancer nod in Schrodinger's boxThe FDA has decided it no longer needs input from external experts on an ovarian cancer indication for GSK’s Zejula. The oncologic drugs advisory committe2022/11/10